Page last updated: 2024-12-11
nifurzide
Description
nifurzide: structure given in first source & in Negwer, 5th ed, #6261 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 9571044 |
CHEMBL ID | 2106530 |
CHEBI ID | 135428 |
SCHEMBL ID | 467248 |
SCHEMBL ID | 467247 |
MeSH ID | M0095082 |
Synonyms (31)
Synonym |
nifurzide |
ricridene |
39978-42-2 |
D07251 |
nifurzide (inn) |
ricridene (tn) |
5-nitro-n'-(3-(5-nitro-2-furyl)allyliden)-2-thiophencarbohydrazid |
einecs 254-728-0 |
nifurzida [inn-spanish] |
nifurzide [inn] |
nifurzidum [inn-latin] |
2-thiophenecarboxylic acid, 5-nitro-, (3-(5-nitro-2-furanyl)-2-propenylidene)hydrazide |
brn 1331076 |
5-nitro-2-thiophenecarboxylic acid (3-(5-nitro-2-furanyl)-2-propenylidine)hydrazide |
n(sup 1)-(5'-nitro-2'-thenoyl)-n(sup 2)-(5''-nitro-2''-furylacryliden) hydrazin [german] |
5-nitro-2-thiophenecarboxylic acid (3-(5-nitro-2-furyl)allylidene)hydrazide |
CHEBI:135428 |
n(sup 1)-(5'-nitro-2'-thenoyl)-n(sup 2)-(5''-nitro-2''-furylacryliden) hydrazin |
z35r6k4c26 , |
unii-z35r6k4c26 |
nifurzida |
nifurzidum |
CHEMBL2106530 |
nifurzide [mi] |
2-thiophenecarboxylic acid, 5-nitro-, 2-(3-(5-nitro-2-furanyl)-2-propen-1-ylidene)hydrazide |
nifurzide [who-dd] |
nifurzide [mart.] |
SCHEMBL467248 |
SCHEMBL467247 |
DB13325 |
AKOS040747209 |
Research Excerpts
Overview
Nifurzide is a nitrofuran with antibacterial activity.
Drug Classes (2)
Class | Description |
thiophenes | Compounds containing at least one thiophene ring. |
C-nitro compound | A nitro compound having the nitro group (-NO2) attached to a carbon atom. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 7 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 23.79
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 23.79 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.45 (4.65) | Search Engine Demand Index | 23.28 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 1 (12.50%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |